Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2018

Feb 9, 2018

33899_dirs_2018-02-09_379644b6-6109-4b1f-85ba-f67c2a8338f0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2017-12-31

Reporting Person: ROBINSON TIMOTHY G (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-31 Common Stock F 3800 $69.81 Disposed 24244 Direct
2018-02-07 Common Stock A 1280 Acquired 25524 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-07 Stock Options $66.68 A 4500 Acquired 2028-02-07 Common Stock (4500) Direct

Footnotes

F1: Represents a grant of restricted stock units pursuant to the 2012 Share Incentive Plan, which will vest in three equal installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2: These non-qualified stock options, which were issued to the reporting person under the 2012 Share Incentive Plan, will vest in three equal annual installments beginning on the first anniversary of the grant date.